Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis
NCT02180009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2016-01-28
Summary
In this study, the investigators will dynamically detect the expression of an immune regulator- T cell Ig and mucin domain protein 3 (Tim-3) in patient with sepsis.
Conditions
- Sepsis
- Severe Sepsis
- Septic Shock
Sponsors & Collaborators
-
Beijing Institute of Basic Medical Science
collaborator OTHER -
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Lixin Xie, PhD & MD · Head of Department of Respiratory Medicine,Chinese PLA Gerneral Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
TRIM25 in Septic Patients
NCT07320638 ·Status: ENROLLING_BY_INVITATION
-
MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis
NCT02756559 ·Status: UNKNOWN
-
Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism
NCT02361970 ·Status: COMPLETED
-
The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries
NCT01333657 ·Status: COMPLETED
-
The Changes of CD4+T Lymphocyte Subsets in Septic Patients
NCT01494389 ·Status: UNKNOWN
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms
NCT03379896 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Immunoregulatory Therapy for 2019-nCoV
NCT04268537 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role and Mechanism of Vimentin in Sepsis Patients
NCT03253146 ·Status: UNKNOWN
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
NCT02883595 ·Status: COMPLETED ·Phase: PHASE4
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Biomarkers for the Early Identification of Sepsis in the Emergency Department
NCT02707718 ·Status: COMPLETED
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
NCT05442710 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Thymosin alpha1 for Severe Sepsis
NCT00711620 ·Status: COMPLETED ·Phase: NA
-
Platelet-associated Inflammation in Severe Sepsis
NCT03029039 ·Status: COMPLETED